CHA₂DS₂-VASc

Atrial fibrillation — stroke risk
Congestive heart failure
Hypertension
Diabetes
Previous stroke, TIA, or clot
Vascular disease
Age
Sex
Enter the patient's age to calculate

About this score

When to use

Estimates stroke and systemic thromboembolism risk in adults with atrial fibrillation and has been used as part of oral-anticoagulation decision frameworks. ⁦[1, 3]⁩

Pearls and pitfalls

• In one Danish nationwide cohort without anticoagulation, the one-year thromboembolism rate at score 0 was 0.78 per 100 person-years; this cohort rate is not an estimate for every individual. ⁦[2]⁩
• Female sex adds a point as a risk modifier, not as an independent risk factor. The sex-aware categories shown here reflect the cited 2020 ESC framework. ⁦[3]⁩
• In the derivation cohort (1,084 patients of the Euro Heart Survey), all stroke-risk schemes compared, including this one, had only modest predictive value. ⁦[1]⁩
• The 2024 ESC guideline uses CHA₂DS₂-VA, the same score without the sex criterion, in the absence of other locally validated alternatives; it is available as its own calculator. ⁦[4]⁩

About the condition

Atrial fibrillation is associated with ischaemic stroke and systemic embolism; the score informs guideline-based oral-anticoagulation decisions but does not make an individual treatment decision. ⁦[3]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach.
Chest, 2010
Open source
[2] Validation
Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. CHA₂DS₂-VASc reliably identifies patients who are truly low risk.
BMJ, 2011
Open source
[3] Guideline
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation (developed with EACTS). This app uses the guideline-era sex-aware CHA₂DS₂-VASc score categories.
European Heart Journal, 2021
Open source
[4] Further source
Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
European Heart Journal, 2024
Open source
Last reviewed: 2026-09
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore